Hi Team,

Sorry for the delay....the minutes and link to meeting recording for the June 20th meeting of the *standard sub-team* of the PDDI Info Model Task Force are pasted below. Thanks to Elizabeth Garcia for writing them!

Kind regards, -R


   Minutes for 6/20/2016 (Standard subgroup)

In Attendance: Mathias Brochhausen, Kim Nolen, Oya Beyan, Clément Goehrs, Michel Dumontier, Richard Boyce, Louisa Zhang, Elizabeth Garcia

Meeting recording: http://goo.gl/X4SVzG

Meeting:

 *

   Update on the PDDIs to focus on

     o

       Content team progress on drug-drug interactions

     o

       Spreadsheet: Suggested potential drug-drug interactions
       
<https://docs.google.com/spreadsheets/d/1DIeIuo7tZ6nVvd6MdO2xzzLtOSPXjAHI-DdBe9M3kiw/edit#gid=716618333>

         +

           Includes drug pairs that are somewhat representative of the
           minimum information items

         +

           Highlighting:  Decision Tree has been developed that will
           guide the evidence and grading the interaction

             #

               Not computable, but it’s important because the minimum
               info model will be based off of this

             #

               Where it fits in with the task force’s goals:
                 information items based off of expert consensus from
               prior work

             #

               Demonstrating usefulness:  need specific interactions to
               focus on & important factors about those interactions

 *

   Progress on clinical consequence and evidence definitions(Elizabeth)

     o

       User-Centered Definitions
       
<https://docs.google.com/document/d/1MGPXSkRZVXCd8nzhEgHJLLSxYLhcixiNPqnAmty---M/edit?usp=sharing>(allows
       for further comments)

     o

       We will be using these definitions to develop a new ontology for
       the minimum information model

     o

       All comments collected through Qualtrics surveys and prior work
       will be incorporated into appendices that will be part of the
       W3C document

     o

       Clinical Consequences:  no disagreement

     o

       Evidence

         +

           Discussion about scope (i.e., human vs. animal), does not
           address information important for CDS

             #

               Definition is broad enough to include elements like
               study design or annotation of evidence

         +

           Mathias will send out evidence work done so far (not to be
           shared outside of the task force)

 *

   Progress on user scenarios and use cases(Elizabeth)

     o

       Louisa and Elizabeth have created a list of information needs
       based on the user stories and stakeholder descriptions developed
       by the task force

         +

           Draft document: PDDI User Information Needs
           
<https://docs.google.com/document/d/1EhHudBgH4TqNdqULZKJYp2tgyO2QtHANdbFSXH5rlUg/edit?usp=sharing>

         +

           Next steps are to synthesize the information needs into user
           stories

     o

       Medication Reconciliation Use Cases:  essential queries we’d
       want to the information model to support

         +

           Hospital pharmacist and consultant pharmacist

         +

           Draft medication reconciliation use cases will be added to
           PDDI site by July 1

     o

       Targeted and open-ended questions will be sent out to solicit
       feedback

 *

   Progress on setting the scope(Mathias)

     o

       Knowledge Representation Core Considerations
       
<https://docs.google.com/document/d/14saXL4qhusPHxxN1Aymc5z_u7vH3j3V-YF9TKNjRxLQ/edit#heading=h.rrsinxzgxju8>

         +

           To what extent the knowledge representation should address
           issues relating to data integrity

         +

           New effort outside the core considerations to address these
           concerns

         +

           Useful discussion to have from the perspective of mode of
           representation

             #

               Not what we represent, but how we represent information

     o

       Next meeting:  July 7th, 9:00 AM – 10:00 AM CST

         +

           Goal:  to wrap up the core consideration document and get it
           to a point to share with the Content group

         +

           Standard sub-team members are welcome to attend

     o

       Goal is to get this into W3C document

     o

       Awaiting the first draft of the use cases

 *

   Future user-centered definitions

     o

       Frequency of adverse events (exposure vs. harm)

         +

           Complex; may take a few months to develop

     o

       Mechanism of Interaction

         +

           DINTO and DIDEO have done a lot of work addressing

 *

   Follow up for July

     o

       July 7thmeeting re: Knowledge Representation Core Considerations

     o

       User Stories and Medication Reconciliation Use Cases in progress

         +

           Medication Reconciliation Use Cases will be discussed at
           all-team meeting

     o

       Decision Trees (Content group will be developing)

     o

       Close to submitting manuscript – systematic search for
       literature discussing information needs

     o Writing:  by the end of July, we should have the beginnings of a
       W3C note taking shape


Reply via email to